2016-04-28 20:24:52 UTC

Cirrhosis and Transplantation

Chicago, IL.




Review of treatments for Cirrhosis:

Download the session audio:

MP3 File

Download the PowerPoint presentation:

PPT File

About the Instructors

Paul Hayashi, MD, MPH

Dr. Hayashi is currently Medical Director of Liver Transplantation at the University of North Carolina but was trained in several places before arriving there.  He got his bachelors in microbiology at UCLA and medical degree at the University of California, San Diego.  He completed his residency and gastroenterology fellowship at the University of California, Davis Medical Center.  Thereafter he left California holding several clinical and academic positions as well as doing graduate work.  Dr. Hayashi spent 2 years at the NIH completing a clinical research fellowship in the Liver Disease Section of the NIDDK in Bethesda, Maryland.  After that he was on faculty at Loma Linda University in California.  He then volunteered for the U.S. Air Force Medical Corp and was stationed outside Tokyo, Japan for 3 years before being transferred to Lackland Air Force Base, San Antonio, Texas. Dr. Hayashi was on faculty with the Air Force’s Gastroenterology Division and did clinical research in liver disease.  After leaving the Air Force, he completed a liver transplant fellowship at the University of Colorado in Denver and then a Masters in Public Health at Saint Louis University, St. Louis, Missouri.  While getting his Masters, he was on faculty at Saint Louis University as a transplant hepatologist. Now at University of North Carolina, he is currently involved in clinical research regarding transplant outcomes, hepatocellular carcinoma screening, cirrhosis management and drug induced liver injury.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.